Dr Suxiang (John) Chen is a molecular biologist specializing in antisense oligonucleotide (ASO) research at Murdoch University. His technical expertise spans ASO sequence design, chemical modification strategies for efficacy optimization, and the practical application of different ASO mechanisms of action. Dr Chen has authored over 20 peer-reviewed articles within the ASO field and holds two granted patents (Australia and Canada).